NIH-funded research R01 grant

Improving heart and blood vessel health by enhancing nerve activity

Official title: Enhancing parasympathetic activity to reduce vascular oxidative stress and endothelial dysfunction

Funded at Vanderbilt University Medical Center · NIH-10857152 · Data updated 2026-11-12

This study is looking at how a medication called galantamine can help improve heart health by reducing stress in blood vessels, especially for African Americans who often face higher risks of heart problems.

More Oxidative Stress research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startJune 1, 2021
Project endMay 31, 2026
Funding year2024
Award (this year)$747,710
NIH project number5R01HL157584-04
Project IDNIH-10857152 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are African American individuals who are at risk for cardiovascular disease and have signs of endothelial dysfunction.

Less likely to help

Patients who do not have endothelial dysfunction or are not of African American descent may not benefit from this research.

What this research studies

This research investigates how enhancing the activity of the parasympathetic nervous system can reduce oxidative stress and improve endothelial function, which is crucial for cardiovascular health. The study focuses on African Americans, who are known to have higher rates of cardiovascular disease and impaired endothelial function. By using an acetylcholinesterase inhibitor called galantamine, the research aims to block harmful oxidative stress and inflammation in blood vessels. Patients may be monitored for changes in vascular reactivity and overall cardiovascular health during the treatment period.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve cardiovascular health and reduce disease risk for patients, particularly in African American populations.

How similar studies have gone: Previous studies have shown promising results in using similar approaches to enhance parasympathetic activity and improve cardiovascular outcomes, particularly in populations with known disparities.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Shibao, Cyndya Adriana — Vanderbilt University Medical Center
  • Study coordinator: Shibao, Cyndya Adriana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.